40–49 | 50–59 | 60–69 | |
Symptoms | |||
P5 | 0.0 | 0.0 | 0.0 |
P10 | 0.0 | 0.0 | 0.0 |
P20 | 0.0 | 0.0 | 0.0 |
P30 | 0.0 | 0.0 | 0.0 |
P40 | 0.0 | 0.0 | 2.32 |
P50/median | 4.42 | 4.24 | 4.42 |
P60 | 6.75 | 8.80 | 8.13 |
P70 | 8.80 | 9.69 | 9.54 |
P80 | 12.17 | 14.08 | 14.29 |
P90 | 18.79 | 19.28 | 28.18 |
P95 | 39.21 | 23.76 | 44.79 |
Mean±sd | 7.24±10.85 | 7.09±8.88 | 9.24±3.43 |
Activity | |||
P5 | 0.0 | 0.0 | 0.0 |
P10 | 0.0 | 0.0 | 0.0 |
P20 | 0.0 | 0.0 | 0.0 |
P30 | 0.0 | 0.0 | 0.0 |
P40 | 0.0 | 0.0 | 5.96 |
P50/median | 5.25 | 6.21 | 12.19 |
P60 | 11.41 | 12.27 | 17.84 |
P70 | 17.12 | 23.28 | 29.31 |
P80 | 20.28 | 29.31 | 41.61 |
P90 | 35.17 | 35.47 | 47.69 |
P95 | 41.08 | 54.42 | 67.02 |
Mean±sd | 10.81±13.99 | 14.29±17.43 | 19.36±22.62 |
Impacts | |||
P5 | 0.0 | 0.0 | 0.0 |
P10 | 0.0 | 0.0 | 0.0 |
P20 | 0.0 | 0.0 | 0.0 |
P30 | 0.0 | 0.0 | 0.0 |
P40 | 0.0 | 0.0 | 0.0 |
P50/median | 0.0 | 0.0 | 0.0 |
P60 | 0.0 | 3.55 | 3.55 |
P70 | 1.90 | 3.55 | 4.06 |
P80 | 4.06 | 7.17 | 8.35 |
P90 | 10.67 | 10.64 | 15.43 |
P95 | 14.38 | 20.43 | 43.03 |
Mean±sd | 2.62±5.63 | 4.10±7.64 | 6.38±13.25 |
Total | |||
P5 | 0.0 | 0.0 | 0.0 |
P10 | 0.0 | 0.0 | 0.0 |
P20 | 0.0 | 0.0 | 1.28 |
P30 | 0.80 | 1.78 | 2.17 |
P40 | 2.17 | 2.82 | 3.34 |
P50/median | 3.75 | 4.44 | 4.26 |
P60 | 5.81 | 8.35 | 9.37 |
P70 | 7.38 | 10.92 | 13.28 |
P80 | 10.95 | 13.04 | 17.76 |
P90 | 15.40 | 17.93 | 25.96 |
P95 | 21.04 | 31.46 | 49.99 |
Mean±sd | 6.09±7.41 | 7.97±9.35 | 11.05±14.83 |
Data are presented as SGRQ scale scores unless otherwise stated
Females from the general population weighted sample (n=329)